T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models

Synopsis

Science Translational Medicine, Volume 18, Issue 873, October 2026.

The publisher’s own description. This is a short summary, not the full story, and may omit important detail.